Company news

Elutia, Inc. news in 2025

Elutia, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development

November 6, 2025

Elutia to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

October 23, 2025

Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21

October 14, 2025

Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors

October 10, 2025

Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million

October 1, 2025

Elutia Announces Newly Published Clinical Data Demonstrating that Biologic Envelopes Support CIED Stabilization and Ease of Reoperation

September 16, 2025

Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million

September 9, 2025

Elutia Selected to Exhibit EluPro™ Antibiotic Eluting BioEnvelope at Vizient Innovative Technology Exchange

September 4, 2025

Elutia to Participate in Upcoming Investor Conferences

August 27, 2025

Elutia Delivers Robust Growth on the Strength of EluPro™ Market Adoption

August 14, 2025

Elutia to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025

July 31, 2025

Dr. Michelle LeRoux Williams Earns Washington Business Journal’s Medical Device Innovator Award

July 31, 2025

New Evidence Supports the Value of Elutia’s Antibiotic-Eluting Platform for Implantable Devices

July 1, 2025

Elutia Wins Dual Honors for Innovation and Product Launches at 2025 Medical Device Network Excellence Awards

June 26, 2025

Elutia Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro™ Testing Method

May 28, 2025

Elutia Announces Strong First Quarter 2025 Financial Results Driven by 84% Sequential Growth in EluPro™ Sales

May 8, 2025

Elutia Transitions to Direct Distribution of Its Cardiovascular Product Portfolio

May 1, 2025

Elutia to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025

May 1, 2025

Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29

April 22, 2025

Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice

April 21, 2025

Elutia Confirms No Material Impact from Global Tariffs

April 14, 2025

EluPro™ Named as 2025 Edison Award Winner

April 4, 2025

Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes

April 2, 2025

Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™

March 27, 2025

Elutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic Envelope

March 25, 2025

Elutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-Out

March 6, 2025

Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025

February 20, 2025

Elutia Announces $15.0 Million Registered Direct Offering

February 2, 2025

Elutia Announces Full Launch of EluPro™ Following Strong Initial Demand

January 13, 2025

Elutia Announces EluPro™ GPO Agreement with Southern Strategic Sourcing Partners

January 5, 2025

Calls in 2025

Decks in 2025